For citations:
Melnichenko G.A., Dzeranova L.K., Pigarova E.A., Vorotnikova S.Yu. Comparative efficacy and safety of generic (Bergolak) vs. brand cabergoline in the treatment of patients with prolactin-secreting tumors. Obesity and metabolism. 2015;12(1):40-44. (In Russ.) https://doi.org/10.14341/omet2015140-44
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
